Premium
Molecular findings and clinical data in a cohort of 150 patients with anophthalmia/microphthalmia
Author(s) -
Chassaing N.,
Causse A.,
Vigouroux A.,
Delahaye A.,
Alessandri J.L.,
BoespflugTanguy O.,
BouteBenejean O.,
Dollfus H.,
DubanBedu B.,
GilbertDussardier B.,
Giuliano F.,
Gonzales M.,
HolderEspinasse M.,
Isidor B.,
Jacquemont M.L.,
Lacombe D.,
MartinCoignard D.,
MathieuDramard M.,
Odent S.,
Picone O.,
Pinson L.,
Quelin C.,
Sigaudy S.,
Toutain A.,
ThauvinRobinet C.,
Kaplan Josseline,
Calvas Patrick
Publication year - 2014
Publication title -
clinical genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.543
H-Index - 102
eISSN - 1399-0004
pISSN - 0009-9163
DOI - 10.1111/cge.12275
Subject(s) - anophthalmia , microphthalmia , pax6 , homeobox , testis determining factor , biology , genetics , genetic heterogeneity , gene , sox2 , transcription factor , y chromosome , phenotype
Anophthalmia and microphthalmia ( AM ) are the most severe malformations of the eye, corresponding respectively to reduced size or absent ocular globe. Wide genetic heterogeneity has been reported and different genes have been demonstrated to be causative of syndromic and non‐syndromic forms of AM . We screened seven AM genes [ GDF6 (growth differentiation factor 6), FOXE3 (forkhead box E3), OTX2 (orthodenticle protein homolog 2), PAX6 (paired box 6), RAX (retina and anterior neural fold homeobox), SOX2 (SRY sex determining region Y‐box 2), and VSX2 (visual system homeobox 2 gene)] in a cohort of 150 patients with isolated or syndromic AM . The causative genetic defect was identified in 21% of the patients (32/150). Point mutations were identified by direct sequencing of these genes in 25 patients (13 in SOX2 , 4 in RAX , 3 in OTX2 , 2 in FOXE3 , 1 in VSX2 , 1 in PAX6 , and 1 in GDF6 ). In addition eight gene deletions (five SOX2 , two OTX2 and one RAX ) were identified using a semi‐quantitative multiplex polymerase chain reaction ( PCR) [quantitative multiplex PCR amplification of short fluorescent fragments ( QMPSF )]. The causative genetic defect was identified in 21% of the patients. This result contributes to our knowledge of the molecular basis of AM , and will facilitate accurate genetic counselling.